• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Marker Therapeutics Inc (NQ: MRKR )

    3.130 +0.050 (+1.62%)
    Streaming Delayed Price Updated: 2:02 PM EDT, Sep 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,837
    Open 3.090
    Bid (Size) 2.920 (2)
    Ask (Size) 3.430 (1)
    Prev. Close 3.080
    Today's Range 2.900 - 3.230
    52wk Range 2.400 - 6.800
    Shares Outstanding 8,922,695
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MRKR Stock Earnings: Marker Therapeutics Beats EPS for Q2 2024
    MRKR stock results show that Marker Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023
    Marker Therapeutics just reported results for the fourth quarter of 2023. 
    Via InvestorPlace

    Performance

    YTD
    -42.67%
    -42.67%
    1 Month
    -21.13%
    -21.13%
    3 Month
    -6.01%
    -6.01%
    6 Month
    -20.96%
    -20.96%
    1 Year
    -45.18%
    -45.18%

    More News

    Read More
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    MRKR Stock Earnings: Marker Therapeutics Reported Results for Q1 2024
    Via InvestorPlace
    Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    What's Going On With Marker Therapeutics (MRKR) Stock
    Via Benzinga
    Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 12/11
    Via Investor Brand Network
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?
    Via Benzinga
    Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies
    Via Newsfile
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 7/24
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Marker Therapeutics (MRKR) Stock Is Trading Sharply Higher
    Via Benzinga
    Nasdaq Gains 1%; US Budget Deficit Widens In May
    Via Benzinga
    Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.